March 27, 2025 - 03:23

As the Minnesota Twins gear up for their season opener, Target Field is set to unveil a groundbreaking entry technology that promises to enhance the fan experience. The new "GoAhead" technology allows fans to use facial recognition as their ticket, streamlining the entry process and improving security measures at the ballpark.
This innovative system eliminates the need for physical tickets, enabling fans to simply approach the entrance where their faces will be scanned and verified against their ticket information. This not only expedites the entry process but also adds a layer of convenience for attendees, who can now bypass traditional ticketing methods.
The Twins are excited about this advancement, believing it will significantly improve the overall experience for fans attending games. With the opening day just around the corner, the team is eager to showcase this modern approach to stadium entry, setting a new standard for sporting events. Fans can look forward to a seamless entry process as they cheer on their team this season.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...